Cu-Catalyzed Amination of Base-Sensitive Aryl Bromides and the Chemoselective N- and O-Arylation of Amino Alcohols-Reference-Cited by-同舟云学术

Cu-Catalyzed Amination of Base-Sensitive Aryl Bromides and the Chemoselective N- and O-Arylation of Amino Alcohols

Published:2024-06-26 Issue:27 Volume:146 Page:18616-18625
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Strauss Michael J.¹^ORCID,Liu Kaylee X.¹²^ORCID,Greaves Megan E.¹,Dahl Jakob C.¹³^ORCID,Kim Seoung-Tae¹^ORCID,Wu Yong-Jin⁴^ORCID,Schmidt Michael A.⁵^ORCID,Scola Paul M.⁴,Buchwald Stephen L.¹^ORCID

Affiliation:

1. Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, United States

2. Department of Chemistry, Wellesley College, 106 Central St., Wellesley, Massachusetts 02481, United States

3. Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, United States

4. Department of Discovery Chemistry, Bristol Myers Squibb, 250 Water St., Cambridge, Massachusetts 02141, United States

5. Chemical Process Development, Bristol Myers Squibb, 1 Squibb Dr. New Brunswick, New Jersey 08901, United States

Funder

Bristol Myers Squibb Foundation

Arnold and Mabel Beckman Foundation

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/jacs.4c05246

Reference60 articles.

1. Discovery and Characterization of the Topical Soft JAK Inhibitor CEE321 for Atopic Dermatitis

2. A Convergent Synthesis of HPK1 Inhibitor GNE-6893 via Palladium-Catalyzed Functionalization of a Tetrasubstituted Isoquinoline

3. Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer

4. Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase

5. Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of Appetite Loss